DOLs

Digital

Pharma companies are turning to digital opinion leaders (DOLs) to fight misconceptions, raise disease awareness, and promote their products.

News

Biogen will advance its tau-targeting Alzheimer's disease drug diranersen into phase 3, even though it missed the main endpoint in a midstage trial.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.